PRESS RELEASE published on 11/06/2025 at 13:00, 1 year ago Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates Moderna, Inc. reports Q3 revenue of $1.0B with a net loss of $(0.2)B. Narrows 2025 revenue range and improves operating expenses. Business updates and financial results detailed Financial Results Moderna Inc. Business Updates Operating Expenses Q3 Revenue
BRIEF published on 11/03/2025 at 13:05, 1 year ago Moderna Initiates Phase 1/2 Trial for Multiple Myeloma Therapy Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 11/03/2025 at 13:05, 1 year ago Moderna lance un essai de phase 1/2 pour un traitement du myélome multiple Moderna Myélome Multiple Étude De Phase 1/2 ARNm-2808 Engager Les Lymphocytes T
PRESS RELEASE published on 11/03/2025 at 13:00, 1 year ago Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma Moderna doses first patient with mRNA-2808 in Phase 1/2 study for multiple myeloma. Targets validated myeloma-associated antigens to combat resistance mechanisms Moderna Multiple Myeloma Phase 1/2 Study MRNA-2808 T-Cell Engager
BRIEF published on 10/23/2025 at 20:47, 1 year ago Moderna reconnue comme l'un des meilleurs employeurs pour la onzième année consécutive Innovation Moderne ARNm Meilleur Employeur MNEXSPIKE
BRIEF published on 10/23/2025 at 20:47, 1 year ago Moderna Recognized as Top Employer for Eleventh Year in a Row Innovation Moderna MRNA Top Employer MNEXSPIKE
PRESS RELEASE published on 10/23/2025 at 20:42, 1 year ago Moderna Named a Top Employer by Science for Eleventh Consecutive Year Moderna, Inc. named a top employer in biopharmaceutical industry by Science for 2025. Recognized for innovation, commitment, and culture Moderna Inc. Biopharmaceutical Industry MRNA Technology Top Employer Science Survey
BRIEF published on 10/23/2025 at 13:05, 1 year ago Moderna to Host Investor Event on November 20, 2025 Webcast MRNA Technology Moderna Investor Event Analyst Day
BRIEF published on 10/23/2025 at 13:05, 1 year ago Moderna organise un événement pour les investisseurs le 20 novembre 2025 Webcast Moderne Événement Pour Les Investisseurs Technologie De L'ARNm Journée Des Analystes
PRESS RELEASE published on 10/23/2025 at 13:00, 1 year ago Moderna to Host Investor Event - Analyst Day Moderna, Inc. to host Investor Event discussing development and commercial strategy. Live webcast available on website. Leading in mRNA medicine Webcast MRNA Medicine Moderna Investor Event Development Strategy
Published on 11/14/2026 at 12:56, 22 hours 31 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 9 hours ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 10 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 10 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 11 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 12 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 13 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 16 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 16 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 23 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 23 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 2 days 3 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 12 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
